Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CC-90011 |
Synonyms | |
Therapy Description |
CC-90011 is an inhibitor of KDM1A (LSD1), which potentially increases H3K4 methylation leading to growth inhibition of LSD1-overexpressing cancer cells (PMID: 31801559). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
CC-90011 | CC90011|CC 90011 | KDM1A Inhibitor 15 | CC-90011 is an inhibitor of KDM1A (LSD1), which potentially increases H3K4 methylation leading to growth inhibition of LSD1-overexpressing cancer cells (PMID: 31801559). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02875223 | Phase I | CC-90011 | A Safety and Efficacy Study of CC-90011 in Subjects With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas | Terminated | ITA | GBR | FRA | ESP | 1 |